Bio Key International (BKYI) Cost of Revenue (2010 - 2026)

Bio Key International has reported Cost of Revenue for 17 years, with the latest figure at $376300.0 in Q1 2026.

• Quarterly Cost of Revenue rose 34.63% year-over-year to $376300.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 15.8% YoY) and the FY2025 annual result came in at $1.4 million, up 6.49% from the prior year.
• Cost of Revenue climbed to $376300.0 in Q1 2026 per BKYI's latest filing, from $271371.0 in the prior quarter.
• Over five years, Cost of Revenue peaked at $1.9 million in Q4 2023 and troughed at $262272.0 in Q2 2024.
• A 5-year average of $694228.1 and a median of $393783.0 in 2022 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2023 and 2024: Cost of Revenue soared 291.26% in 2023, then plunged 86.34% in 2024.
• Over 5 years, Cost of Revenue stood at $984393.0 in 2022, then jumped by 95.1% to $1.9 million in 2023, then slumped by 86.34% to $262360.0 in 2024, then climbed by 3.43% to $271371.0 in 2025, then soared by 38.67% to $376300.0 in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $376300.0, $271371.0, and $357988.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.